Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia.
Karin G E
KG
Miedema
Eveline S J M
ES
de Bont
Claudi S M
CS
Oude Nijhuis
Danique
D
van Vliet
Willem A
WA
Kamps
Wim J E
WJ
Tissing
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D008297:Male; D015233:Models, Statistical; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009503:Neutropenia / Q000139:chemically induced* / Q000453:epidemiology; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment
D000970:Antineoplastic Agents